Title 42 — The Public Health and WelfareRelease 119-83
§254c–2 Special diabetes programs for type I diabetes
Title 42 › Chapter CHAPTER 6A— - PUBLIC HEALTH SERVICE › Subchapter SUBCHAPTER II— - GENERAL POWERS AND DUTIES › Part Part D— - Primary Health Care › Subpart subpart i— - health centers › § 254c–2
Summary
The Secretary must fund research to prevent and cure Type I diabetes. The funding can be given directly or by awards (grants) to other groups. Money was set aside for those grants in specific years. From fiscal years 1998 through 2002, $30,000,000 was transferred each year for these grants. For fiscal years 2001 and 2002, an extra $70,000,000 was provided and combined with the $30,000,000 for those years. The law also provides $100,000,000 for 2003; $150,000,000 each year for 2004–2017; $150,000,000 each year for 2018–2023 (available until spent); $155,619,196 for 2024 (available until spent); $159,228,188 for 2025 (available until spent); $200,000,000 for 2026 (available until spent); and $50,410,959 for the period October 1, 2026 through December 31, 2026 (available until spent).
Full Legal Text
Title 42, §254c–2
The Public Health and Welfare — Source: USLM XML via OLRC
(a)The Secretary, directly or through grants, shall provide for research into the prevention and cure of Type 11 So in original. Probably should not be capitalized. I diabetes.
(b)(1)Notwithstanding section 1397dd(a) of this title, from the amounts appropriated in such section for each of fiscal years 1998 through 2002, $30,000,000 is hereby transferred and made available in such fiscal year for grants under this section.
(2)For the purpose of making grants under this section, there is appropriated, out of any funds in the Treasury not otherwise appropriated—
(A)$70,000,000 for each of fiscal years 2001 and 2002 (which shall be combined with amounts transferred under paragraph (1) for each such fiscal years);
(B)$100,000,000 for fiscal year 2003;
(C)$150,000,000 for each of fiscal years 2004 through 2017;
(D)$150,000,000 for each of fiscal years 2018 through 2023, to remain available until expended;
(E)$155,619,196 for fiscal year 2024, to remain available until expended;
(F)$159,228,188 for fiscal year 2025, to remain available until expended;
(G)$200,000,000 for fiscal year 2026, to remain available until expended; and
(H)$50,410,959 for the period beginning on October 1, 2026, and ending on December 31, 2026, to remain available until expended.
Legislative History
Notes & Related Subsidiaries
Editorial Notes
Amendments
2026—Subsec. (b)(2)(E) to (H). Pub. L. 119–75 added subpars. (E) to (H) and struck out former subpars. (E) to (H) which read as follows: “(E) $19,726,027 for the period beginning on
October 1, 2023, and ending on
November 17, 2023, $25,890,411 for the period beginning on
November 18, 2023, and ending on
January 19, 2024, $20,136,986 for the period beginning on
January 20, 2024, and ending on
March 8, 2024, and $130,000,000 for the period beginning on
March 9, 2024, and ending on
December 31, 2024, to remain available until expended; “(F) $39,261,745 for the period beginning on
January 1, 2025, and ending on
March 31, 2025, to remain available until expended; “(G) $79,832,215 for the period beginning on
April 1, 2025, and ending on
September 30, 2025, to remain available until expended; and “(H) $53,145,205 for the period beginning on
October 1, 2025, and ending on
January 30, 2026, to remain available until expended.” 2025—Subsec. (b)(2)(G). Pub. L. 119–4 added subpar. (G). Subsec. (b)(2)(H). Pub. L. 119–37 added subpar. (H). 2024—Subsec. (b)(2)(E). Pub. L. 118–42 substituted “$20,136,986 for the period beginning on
January 20, 2024, and ending on
March 8, 2024, and $130,000,000 for the period beginning on
March 9, 2024, and ending on
December 31, 2024” for “and $20,136,986 for the period beginning on
January 20, 2024, and ending on
March 8, 2024”. Pub. L. 118–35 substituted “$25,890,411 for the period beginning on
November 18, 2023, and ending on
January 19, 2024, and $20,136,986 for the period beginning on
January 20, 2024, and ending on
March 8, 2024” for “and $25,890,411 for the period beginning on
November 18, 2023, and ending on
January 19, 2024”. Subsec. (b)(2)(F). Pub. L. 118–158 added subpar. (F). 2023—Subsec. (b)(2)(E). Pub. L. 118–22 substituted “$19,726,027 for the period beginning on
October 1, 2023, and ending on
November 17, 2023, and $25,890,411 for the period beginning on
November 18, 2023, and ending on
January 19, 2024” for “$19,726,027 for the period beginning on
October 1, 2023, and ending on
November 17, 2023”. Pub. L. 118–15 added subpar. (E). 2020—Subsec. (b)(2)(D). Pub. L. 116–260 substituted “2023” for “2020, and $32,465,753 for the period beginning on
October 1, 2020, and ending on
December 18, 2020”. Pub. L. 116–215 substituted “$32,465,753” for “$29,589,042” and “
December 18, 2020” for “
December 11, 2020”. Pub. L. 116–159 substituted “$29,589,042” for “$25,068,493” and “
December 11, 2020” for “
November 30, 2020”. Pub. L. 116–136 substituted “through 2020, and $25,068,493 for the period beginning on
October 1, 2020, and ending on
November 30, 2020” for “and 2019, and $96,575,342 for the period beginning on
October 1, 2019, and ending on
May 22, 2020”. 2019—Subsec. (b)(2)(D). Pub. L. 116–94 substituted “$96,575,342” for “$33,287,671” and “
May 22, 2020” for “
December 20, 2019”. Pub. L. 116–69 substituted “$33,287,671” for “$21,369,863” and “
December 20, 2019” for “
November 21, 2019”. Pub. L. 116–59 inserted “and $21,369,863 for the period beginning on
October 1, 2019, and ending on
November 21, 2019,” before “to remain available”. 2018—Subsec. (b)(2)(D). Pub. L. 115–123 amended subpar. (D) generally. Prior to amendment, subpar. (D) read as follows: “$37,500,000 for the period of the first and second quarters of fiscal year 2018, to remain available until expended.” 2017—Subsec. (b)(2)(D). Pub. L. 115–96 added subpar. (D). 2015—Subsec. (b)(2)(C). Pub. L. 114–10 substituted “2017” for “2015”. 2014—Subsec. (b)(2)(C). Pub. L. 113–93 substituted “2015” for “2014”. 2013—Subsec. (b)(2)(C). Pub. L. 112–240 substituted “2014” for “2013”. 2010—Subsec. (b)(2)(C). Pub. L. 111–309 substituted “2013” for “2011”. 2008—Subsec. (b)(2)(C). Pub. L. 110–275 substituted “2011” for “2009”. 2007—Subsec. (b)(2)(C). Pub. L. 110–173 substituted “2009” for “2008”. 2002—Subsec. (b)(2)(C). Pub. L. 107–360 added subpar. (C). 2000—Subsec. (b). Pub. L. 106–554 designated existing provisions as par. (1), inserted par. heading, and added par. (2). 1997—Pub. L. 105–34, § 1604(f)(1)(B), amended directory language of Pub. L. 105–33, § 4921, which enacted this section. Pub. L. 105–34, § 1604(f)(1)(C)(i), struck out “children with” before “type I diabetes” in section catchline. Subsec. (a). Pub. L. 105–34, § 1604(f)(1)(C)(ii), amended heading and text of subsec. (a) generally. Prior to amendment, text read as follows: “The Secretary shall make grants for services for the prevention and treatment of type I diabetes in children, and for research in innovative approaches to such services. Such grants may be made to children’s hospitals; grantees under section 254b of this title and other federally qualified health centers; State and local health departments; and other appropriate public or nonprofit private entities.”
Statutory Notes and Related Subsidiaries
Effective Date
of 1997 Amendment Pub. L. 105–34, title XVI, § 1604(f)(4), Aug. 5, 1997, 111 Stat. 1099, provided that: “The provisions of, and
Amendments
made by, this subsection [amending this section and provisions set out as a note under section 5701 of Title 26, Internal Revenue Code] shall take effect immediately after the sections referred to in this subsection [section 4921, 9302, 11104, and 11201 of Pub. L. 105–33] take effect.” Report on Diabetes Grant Programs Pub. L. 105–33, title IV, § 4923, Aug. 5, 1997, 111 Stat. 574, as amended by Pub. L. 106–554, § 1(a)(6) [title IX, § 931(c)], Dec. 21, 2000, 114 Stat. 2763, 2763A–585; Pub. L. 107–360, § 1(c), Dec. 17, 2002, 116 Stat. 3019; Pub. L. 109–482, title I, § 104(b)(3)(C), Jan. 15, 2007, 120 Stat. 3694; Pub. L. 110–275, title III, § 303(c), July 15, 2008, 122 Stat. 2594, provided that: “(a) Evaluation.—The Secretary of Health and Human Services shall conduct an evaluation of the diabetes grant programs established under the
Amendments
made by this chapter [chapter 3 (§§ 4921–4923) of subtitle J of title IV of Pub. L. 105–33, enacting this section and section 254c–3 of this title]. “[(b) Repealed. Pub. L. 109–482, title I, § 104(b)(3)(C), Jan. 15, 2007, 120 Stat. 3694.]” [Pub. L. 110–275, § 303(c), which directed amendment of section 4923(b) of Pub. L. 105–33 by substituting “a second interim report” for “a final report” in par. (2) and by adding par. (3) at end to read “a report on such evaluation not later than January 1, 2011.”, could not be executed because of prior repeal.]
Reference
Citations & Metadata
Citation
42 U.S.C. § 254c–2
Title 42 — The Public Health and Welfare
Last Updated
Apr 18, 2026
Release point: 119-83